Radiopharmacy Blog

European Congress of Nuclear Medicine EANM 2018

Posted on 11 June, 2018 by Tablón de Radiofarmacia

The European Congress of 2018 of the EANM will take place in Düsseldorf from October 13 to 17.

FDA approves new treatment for certain digestive tract cancers

Posted on 16 February, 2018 by Tablón de Radiofarmacia

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This is the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of GEP-NETs. Lutathera is indicated for adult patients with somatostatin receptor-positive GEP-NETs.

More information

Posted in News | Leave a comment

International Conference on Nuclear Medicine and Radiation Therapy

Posted on 8 January, 2018 by Tablón de Radiofarmacia

International Conference on Nuclear Medicine and Radiation Therapy

Madrid, Spain July 16-17, 2018

Posted in Congress | Leave a comment

19th European Symposium on Radiopharmacy and Radiopharmaceuticals

Posted on 20 December, 2017 by Tablón de Radiofarmacia

19th European Symposium on Radiopharmacy and Radiopharmaceuticals.

April 05-08, 2018 • Groningen, Netherlands

Link

Posted in Congress | Leave a comment

New version of Radiolab

Posted on 24 May, 2017 by Tablón de Radiofarmacia

A new version of Radiolab -application for comprehensive management of hospital radiopharmacies- is now available at www.radiopharmacy.net. Radiolab 4.0 includes among others the following new features:

Addition of small, medium and large labels for radioactive products and cold kits.
Addition of Ga-68 generator in the Generators module.
Each user can change their own password in the Maintenance module without relying on the Administrator. This new functionality is only active in the registered versions of Radiolab.
The activity of the radionuclides in the Waste module is now shown in mCi and Bq. Only those radionuclides having at least a residual activity of 0.01 Bq are shown.
The user who made the last backup of the Radiolab database is registered, and also when and where they made the backup is registered.
Effective doses are automatically calculated at two different times. Firstly, they are automatically calculated when you import the prescriptions in the Prescriptions section of the Dispensing module. And secondly, each effective dose is automatically recalculated when the administered radiopharmaceutical, its activity or the patient’s age is modified in the Dispensing module.
The Dosimetry section has been included in the Traceability module, which allows the reporting of the effective doses of all radiopharmaceuticals administered to every patient, as well as the cumulative total effective dose of all of them.